Back to results
US 10,870,678 B2Granted
Chiral peptides
AssigneeArcuate Therapeutics, Inc.
InventorAndrew D. Levin
Life of this patent
Estimating the term…
Abstract
The present disclosure provides certain chiral peptide agents, and uses relating thereto.
Claims14
A tetrameric peptide agent having sequence (D-Phe)(D-Orn)(D-Tyr)(L-Orn)-NH2.
A method of inhibiting mitochondrial respiration in a patient or in a biological sample, the method comprising a step of administering to said patient or contacting said biological sample with a peptide agent having sequence (D-Phe)(D-Orn)(D-Tyr)(L-Orn)-NH2.
Dependencies are inferred from the claim text.